Spineology

Spineology reported that one-year outcomes data for its OptiMesh Expandable Interbody Fusion System showed reduced pain, improved back function, and high patient-satisfaction scores.

Spineology Inc. announced the appointment of Emory Rooney as executive vice president of sales. Rooney will lead U.S. market growth and sales efforts.

Spineology announced an FDA grant for its proprietary Interbody Fusion System, now called the OptiMesh Expandable Interbody Fusion System.

Spineology raised $25 million in Series AA financing led by SV Health Investors, with participation from 1315 Capital and existing investor RC Capital.

The OptiMesh portfolio includes a conforming, patient-specific expandable implant designed to accommodate individual patient requirements.

Spineology's contact page accepts general inquiries, product demo requests, and inquiries from distributors interested in carrying its products.

Spineology reports advancements in spine surgery and has a team of professionals.

The website and Privacy Statement are intended for a U.S. audience, and the site may collect personal information. Using the website indicates agreement to the latest version of the Privacy Statement.

Spineology introduces **OptiMesh® HA Nano**, the first patient-specific expandable implant with a hydroxyapatite nano-surface. The implant is designed to improve spinal fusion outcomes through a clinically studied surface treatment. The product targets enhanced integration and stability in interbody spinal procedures.

Jan 2026SpineologyNews article

Spineology Inc. launches **OptiMesh Align**, its newest patient-specific spinal solution leveraging **Conform and Expand Technology**. The product builds upon the company’s existing **OptiMesh platform**, targeting advanced customization for spinal procedures. Spineology positions Align as its most sophisticated offering to date, emphasizing precision in patient-specific applications.

Jun 2025SpineologyNews article

Spineology Inc. unveils a new brand identity, logo, and product positioning as part of a rebranding initiative. The company highlights its flagship **OptiMesh® interbody fusion portfolio** and continues to focus on its **Conform and Expand™ Technology**. The rebrand aims to strengthen its market presence in spinal fusion solutions.

Sep 2024SpineologyNews article

Spineology secures $25 million in Series AA funding to advance its OptiMesh technology, a solution in its Conform and Expand product line for spinal procedures. The company leverages this financing to expand its medical device offerings targeting spinal health interventions. OptiMesh integrates with Spineology’s existing portfolio of spinal implants and tools.

Aug 2024Yahoo FinanceNews article